Background: Kisspeptin and its cognate receptor GPR54 are the central driving forces in the hypothalamus-pituitary-gonadal axis essential for sexual maturation and reproduction. Kisspeptin/GPR54 signalling stimulates gonadotropin-releasing hormone (GnRH) neurones and induces pulsatile GnRH release. The molecular signalling pathway by which kisspeptin stimulates GnRH neurones is currently under investigation. Methods: Primary GnRH neurones were isolated from young adult rats and loaded with the calcium indicator Fura Red. Cytosolic calcium was measured while the cells were stimulated with kisspeptin. Results: GnRH neurones show a maintained increase of cytosolic calcium upon stimulation with 100 nM kisspeptin-10. The calcium elevation was inhibited 30% by 1 µM tetrodotoxin, a voltage-gated sodium channel blocker, and 76% by 30 µM SKF96365, an inhibitor of receptor-mediated calcium entry. Furthermore, removal of extracellular calcium completely abolished the kisspeptin-induced calcium elevation. Conclusion: Our results suggest that the major part of the kisspeptin-evoked calcium signal is generated by an action potential-independent calcium influx, possibly through channels of the classical transient receptor potential type, with an additional influx through voltage-gated calcium channels activated by sodium action potentials.

Keywords:
Kisspeptin, Metastin, Signal transduction, Calcium
1.
Krsmanovic LZ, et al: Calcium signaling and episodic secretion of gonadotropin-releasing hormone in hypothalamic neurons. Proc Natl Acad Sci USA 1992;89:8462–8466.
2.
Nunemaker CS, et al: Gonadotropin-releasing hormone neurons generate interacting rhythms in multiple time domains. Endocrinology 2003;144:823–831.
3.
Van Goor F, et al: Control of action potential-driven calcium influx in GT1 neurons by the activation status of sodium and calcium channels. Mol Endocrinol 1999;13:587–603.
4.
Watanobe H: Leptin directly acts within the hypothalamus to stimulate gonadotropin-releasing hormone secretion in vivo in rats. J Physiol 2002;545:255–268.
5.
Smith JT, et al: KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 2006;18:298–303.
6.
Grattan DR, et al: Prolactin regulation of gonadotropin-releasing hormone neurons to suppress luteinizing hormone secretion in mice. Endocrinology 2007;148:4344–4351.
7.
Gottsch ML, et al: A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004;145:4073–4077.
8.
Kuohung W, Kaiser UB: GPR54 and KiSS-1: role in the regulation of puberty and reproduction. Rev Endocr Metab Disord 2006;7:257–263.
9.
Kotani M, et al: The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001;276:34631–34636.
10.
Irwig MS, et al: Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology 2004;80:264–272.
11.
Han SK, et al: Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci 2005;25:11349–11356.
12.
Herbison AE, et al: Distribution and postnatal development of Gpr54 gene expression in mouse brain and gonadotropin-releasing hormone neurons. Endocrinology 2010;151:312–321.
13.
Ohtaki T, et al: Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001;411:613–617.
14.
Messager S, et al: Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci USA 2005;102:1761–1766.
15.
de Roux N, et al: Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003;100:10972–10976.
16.
Seminara SB, et al: The GPR54 gene as a regulator of puberty. N Engl J Med 2003;349:1614–1627.
17.
d’Anglemont de Tassigny X, et al: Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc Natl Acad Sci USA 2007;104:10714–10719.
18.
Lapatto R, et al: Kiss1–/– mice exhibit more variable hypogonadism than Gpr54–/– mice. Endocrinology 2007;148:4927–4936.
19.
Muir AI, et al: AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 2001;276:28969–28975.
20.
Zhang C, et al: Kisspeptin depolarizes gonadotropin-releasing hormone neurons through activation of TRPC-like cationic channels. J Neurosci 2008;28:4423–4434.
21.
Pielecka-Fortuna J, Chu Z, Moenter SM: Kisspeptin acts directly and indirectly to increase gonadotropin-releasing hormone neuron activity and its effects are modulated by estradiol. Endocrinology 2008;149:1979–1986.
22.
Liu X, Lee K, Herbison AE: Kisspeptin excites gonadotropin-releasing hormone (GnRH) neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels. Endocrinology 2008;149:4605–4614.
23.
Constantin S, et al: Kisspeptin-10 facilitates a plasma membrane-driven calcium oscillator in gonadotropin-releasing hormone-1 neurons. Endocrinology 2009;150:1400–1412.
24.
Fujioka H, et al: Generation of transgenic rats expressing enhanced green fluorescent protein in gonadotropin-releasing hormone neurons. J Reprod Dev 2003;49:523–529.
25.
Bolsover SR, Gomez-Fernandez JC, Corbalan-Garcia S: Role of the Ca2+/phosphatidylserine-binding region of the C2 domain in the translocation of protein kinase C alpha to the plasma membrane. J Biol Chem 2003;278:10282–10290.
26.
Charles AC, Hales TG: Mechanisms of spontaneous calcium oscillations and action potentials in immortalized hypothalamic (GT1–7) neurons. J Neurophysiol 1995;73:56–64.
27.
Jasoni CL, et al: Cell type-specific expression of a genetically encoded calcium indicator reveals intrinsic calcium oscillations in adult gonadotropin-releasing hormone neurons. J Neurosci 2007;27:860–867.
28.
Quaynor S, et al: Expression of a functional g protein-coupled receptor 54-kisspeptin autoregulatory system in hypothalamic gonadotropin-releasing hormone neurons. Mol Endocrinol 2007;21:3062–3070.
29.
Merritt JE, et al: SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 1990;271:515–522.
30.
d’Anglemont de Tassigny X, et al: Kisspeptin can stimulate gonadotropin-releasing hormone (GnRH) release by a direct action at GnRH nerve terminals. Endocrinology 2008;149:3926–3932.
31.
Putney JW Jr: A model for receptor-regulated calcium entry. Cell Calcium 1986;7:1–12.
32.
Van Goor F, et al: Coordinate regulation of gonadotropin-releasing hormone neuronal firing patterns by cytosolic calcium and store depletion. Proc Natl Acad Sci USA 1999;96:4101–4106.
33.
Nilius B, Voets T: TRP channels: a TR(I)P through a world of multifunctional cation channels. Pflügers Arch 2005;451:1–10.
34.
Lalo U, Kostyuk P: Developmental changes in purinergic calcium signalling in rat neocortical neurones. Brain Res Dev Brain Res 1998;111:43–50.
35.
Grondahl TO, Hablitz JJ, Langmoen IA: Depletion of intracellular Ca2+ stores or lowering extracellular calcium alters intracellular Ca2+ changes during cerebral energy deprivation. Brain Res 1998;796:125–131.
36.
Ramsey IS, Delling M, Clapham DE: An introduction to TRP channels. Ann Rev Physiol 2006;68:619–647.
37.
Talavera K, Nilius B, Voets T: Neuronal TRP channels: thermometers, pathfinders and life-savers. Trends Neurosci 2008;31:287–295.
38.
Sabatier N, Shibuya I, Dayanithi G: Intracellular calcium increase and somatodendritic vasopressin release by vasopressin receptor agonists in the rat supraoptic nucleus: involvement of multiple intracellular transduction signals. J Neuroendocrinol 2004;16:221–236.
39.
Lu X, Ellis-Davies GC, Levitan ES: Calcium requirements for exocytosis do not delimit the releasable neuropeptide pool. Cell Calcium 2003;33:267–271.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.